Search results
- 6.18Add to watchlist-0.09 (-1.44%)At close:4:00 PM EDTTue. Jul 2, 20246.14 -0.04 (-0.65%)After hrs:6:02 PM EDTTue. Jul 2, 2024Nasdaq Real Time Price (USD) · Market closed
- Open6.24High6.25Low6.01
- Mkt Cap4.27BP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close6.2752 Wk. Low1.2552 Wk. High10.53
Related stocks
5 days ago · Get the latest information on ImmunityBio (IBRX), a clinical-stage immunotherapy company, including its stock price, news, financials, statistics, forecast and profile. See how the company's products and pipeline are performing in the market and the industry.
- Forecast
Stock Price Forecast. The 1 analyst with a 12-month price...
- Chart
Interactive stock price chart for ImmunityBio, Inc. (IBRX)...
- Statistics
Detailed statistics for ImmunityBio, Inc. (IBRX) stock,...
- Financial Statements
Detailed annual and quarterly income statement for...
- Forecast
People also ask
Where can I buy IBRX stock?
Should investors hold IBRX shares?
Does immunitybio (IBRX) pay a dividend?
What is the Brazil IBRX index?
4 days ago · IBRX's current price target is $6.00. Learn why top analysts are making this stock forecast for ImmunityBio at MarketBeat.
- (858) 633-0300
- 3530 JOHN HOPKINS COURT, SAN DIEGO CA, 92121
- investors@nantkwest.com
4 days ago · Should You Buy or Sell ImmunityBio Stock? Get The Latest IBRX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.
- (858) 633-0300
- 3530 JOHN HOPKINS COURT, SAN DIEGO CA, 92121
- investors@nantkwest.com
22 hours ago · Based on insights from the past three months, one analyst has set a consistent 12-month price target for IBRX at $6.00. This target reflects a slight decrease of 4.31% from its recent trading price of $6.27. Such a uniform forecast suggests a cautious but stable perspective on the company’s stock performance in the near term.
5 days ago · See the latest analyst ratings, price targets and revenue forecasts for ImmunityBio, a biotechnology company developing immunotherapies. The stock is expected to decline by 3.23% to 6.00 USD in the next 12 months.
4 days ago · What are your ImmunityBio, Inc. (IBRX) stock predictions? 2 Wall Street analysts have issued ratings. Currently, 1 analysts rated IBRX as Bullish, 0 rated it Bearish, and 1 rated it Neutral.
5 days ago · View ImmunityBio, Inc IBRX investment & stock information. Get the latest ImmunityBio, Inc IBRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.